Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1999-7-20
pubmed:abstractText
To compare the efficacy and the safety of a single intramuscular dose of ceftriaxone, 50 mg/kg, vs. a 10-day course of amoxicillin/clavulanate (amox/clav) therapy, 80 mg/kg/day of amoxicillin: 10 mg/kg/day of clavulanate in three divided doses, in children with acute otitis media (AOM) and to evaluate the changes in nasopharyngeal flora after treatment.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0891-3668
pubmed:author
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
403-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10353511-Acute Disease, pubmed-meshheading:10353511-Amoxicillin-Potassium Clavulanate Combination, pubmed-meshheading:10353511-Anti-Bacterial Agents, pubmed-meshheading:10353511-Ceftriaxone, pubmed-meshheading:10353511-Cephalosporins, pubmed-meshheading:10353511-Child, Preschool, pubmed-meshheading:10353511-Drug Administration Schedule, pubmed-meshheading:10353511-Female, pubmed-meshheading:10353511-Haemophilus influenzae, pubmed-meshheading:10353511-Humans, pubmed-meshheading:10353511-Infant, pubmed-meshheading:10353511-Male, pubmed-meshheading:10353511-Moraxella (Branhamella) catarrhalis, pubmed-meshheading:10353511-Nasopharynx, pubmed-meshheading:10353511-Otitis Media with Effusion, pubmed-meshheading:10353511-Prospective Studies, pubmed-meshheading:10353511-Streptococcus pneumoniae, pubmed-meshheading:10353511-Treatment Outcome
pubmed:year
1999
pubmed:articleTitle
One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora.
pubmed:affiliation
Department of Microbiology and Pediatrics, Intercommunal Hospital of Créteil, France. robert.cohen@wanadoo.fr
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study